Senti Biosciences, Inc.
SNTI
$1.65
$0.0553.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 8.06% | 19.42% | |||
| Gross Profit | -8.06% | -19.42% | |||
| SG&A Expenses | -4.07% | -18.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -17.42% | -- | |||
| Total Operating Expenses | 3.43% | 0.58% | |||
| Operating Income | -3.43% | -0.58% | |||
| Income Before Tax | -4.40% | -2,213.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.40% | -2,213.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.40% | -2,213.44% | |||
| EBIT | -3.43% | -0.58% | |||
| EBITDA | -3.75% | -0.70% | |||
| EPS Basic | 59.92% | -4.91% | |||
| Normalized Basic EPS | 59.92% | -421.55% | |||
| EPS Diluted | 59.92% | -4.91% | |||
| Normalized Diluted EPS | 59.92% | -421.55% | |||
| Average Basic Shares Outstanding | 160.48% | 114.82% | |||
| Average Diluted Shares Outstanding | 160.48% | 114.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||